Organogenesis (ORGO)
Organogenesis Holdings Inc., a regenerative medicine company, develops, manufactures, and commercializes products for the advanced wound care, and surgical and...
- Open
- --
- High
- --
- Low
- --
- Prev. Close
- --
- Volume
- --
- Turnover
- --
- Avg Price
- --
- Bid/Ask Ratio
- --
- Amplitude
- --
- 52wk High
- --
- Volume Ratio
- --
- Turnover Ratio
- --
Organogenesis Analyst Rating
View moreForecast & Rating
Aug 7, 2026Price forecast
$2.0045.45%
Forecast & RatingHold
2analysts
- Strong buy0.00%
- Buy0.00%
- Hold100.00%
- Sell0.00%
- Strong sell0.00%
News
- Tip Ranks · Aug 13 at 02:26 AM
Truist Financial Sticks to Its Hold Rating for Organogenesis Holdings (ORGO)
- Global Report · Aug 11 at 10:13 AM
The Tangible and the Abstract: What UWM’s Derivative Blowup Teaches Us About Business Models
- benzinga_article · Aug 7 at 05:05 PM
12 Health Care Stocks Moving In Friday's Intraday Session
- Market Beat · Aug 7 at 01:36 PM
Truist Financial Has Lowered Expectations for Organogenesis (NASDAQ:ORGO) Stock Price
- benzinga_article · Aug 7 at 12:05 PM
12 Health Care Stocks Moving In Friday's Pre-Market Session
- benzinga_article · Aug 7 at 12:02 PM
Trade Desk Posts Downbeat Q2 Results, Joins Sezzle, Resmed, Ouster And Other Big Stocks Moving Lower In Friday’s Pre-Market Session
